Both in Biotechnology
INmune Bio vs Eloxx Pharmaceuticals
| Metric | INMB | ELOX |
|---|---|---|
| Price | $1.96 | $15.42 |
| Market cap | $54.4M | $53.0M |
| Today | −2.00% | +2.80% |
| 1 month | −15.9% | — |
| 6 months | +71.9% | — |
| Year to date | +25.6% | — |
| 1 year | −2.5% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $18.4M | $62.0M |
| Dividend yield | — | — |
| Volatility (60d) | 71.9% | — |
| Short % of float | 9.5% | 1.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).